StockData
Molecular Partners AG logo

Molecular Partners AG (MOLN) stock

MOLNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 12, 2026Score 1/30
$3.09+0.00 (0.00%)

Close on Nov 11, 2026Market cap $124.76MP/E –Yield –

Molecular Partners statistics

53 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Valuation ratiosIndustry

Market Cap
CHF 102.20M
–
Enterprise Value
CHF 34.27M
–

Share statisticsIndustry

Shares Change (YoY)
9.52%
10.4%
Float
40M
47M
Shares Held by Insiders
0.00%
13.5%
Shares Held by Institutions
8.90%
–

Short sellingIndustry

Short Interest
1
–
Short Interest Change
-99.8%
–
Days to Cover
1.00
–

Stock price statisticsIndustry

Price Change (1 Week)
-4.83%
–
Price Change (1 Month)
-15.8%
–
Price Change (3 Months)
-26.6%
–
Price Change (6 Months)
-22.8%
–
Price Change (YTD)
-29.1%
–
Price Change (1 Year)
-27.3%
–
Price Change (3 Years)
-25.5%
–
Price Change (5 Years)
-79.0%
–
Average Volume (10 Days)
2,032
–
Average Volume (20 Days)
2,161
–
Average Volume (90 Days)
1,791
–
Relative Volume
0.24
–
Relative Strength Index (14)
31.8
–
Volatility (1 Year)
51.4%
–
Beta (5 Years)
0.90
–

Returns on capitalIndustry

Return on Capital Employed (ROCE)
-88.2%
-133.0%

Financial positionIndustry

Current Ratio
7.27
2.65
Quick Ratio
7.05
2.21
Interest Coverage
-11.52
-116.78

GrowthIndustry

Revenue Growth (YoY)
-100.0%
–

EfficiencyIndustry

Asset Turnover
0.00
–
Revenue Per Employee
CHF 0
–
Employee Count
34
49
WACC
9.38%
–

Income statement (TTM)Industry

Revenue
CHF 0
–
Operating Income
-CHF 58.12M
-CHF 69.32M
Pretax Income
-CHF 61.65M
-CHF 70.45M
EBITDA
-CHF 55.98M
-CHF 69.32M
EPS (Diluted)
-1.65 CHF
-1.65 CHF

Balance sheetIndustry

Cash & Short-Term Investments
CHF 67.93M
CHF 27.76M
Net Cash (Debt)
CHF 67.93M
CHF 27.76M
Net Cash Per Share
1.68 CHF
1.03 CHF
Working Capital
CHF 61.61M
CHF 11.40M

Cash flow (TTM)Industry

Operating Cash Flow
-CHF 51.26M
-CHF 51.26M
Capital Expenditures
-CHF 714.00K
-CHF 446.00K
Free Cash Flow
-CHF 51.97M
-CHF 51.97M
FCF Per Share
-1.29 CHF
-1.11 CHF

Dividends and yieldsIndustry

FCF Yield
-50.9%
–
Buyback Yield
0.00%
–
Shareholder Yield
0.00%
–

Taxes and interestIndustry

Interest Expense
CHF 5.05M
CHF 833.00K
Income Tax
CHF 2.00K
CHF 0

Scores and fair valueIndustry

Altman Z-Score
-4.18
–

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

PeriodMOLNS&P 500DifferenceMOLN per yearS&P 500 per year
1 month-19.7%-2.4%−17.3 pts
3 months-25.2%-1.2%−24.0 pts
Year to date-29.1%+12.3%−41.4 pts
1 year-23.3%+12.4%−35.8 pts
3 years-25.5%+78.8%−104.3 pts-9.3%+21.4%
5 years-78.9%+75.2%−154.1 pts-26.7%+11.9%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M MOLN shares were sold short on Oct 30, 2026, down 99.8% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 28.3% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261-99.8%2,2971.0
Oct 15, 2026580+134.8%1,8401.0
Sep 30, 2026247+13.3%1,3591.0
Sep 15, 2026218-0.5%1,0551.0
Aug 31, 2026219+17.1%1,6901.0
Aug 14, 2026187-86.5%1,0111.0
Jul 31, 20261,385-49.3%7901.8
Jul 15, 20262,733+56.1%9,6091.0
Jun 30, 20261,751-84.3%10,3511.0
Jun 15, 202611,177+9.7%4,3092.6
May 29, 202610,189+67.9%7,8081.3
May 15, 20266,068-38.6%5,2291.2

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?